ArticleCureus2025
A Case Report of Cytomegalovirus-Associated Anterior Uveitis With Atypical Bilateral Circumferential Peripheral Iris Atrophy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cytomegalovirus-associated anterior uveitis (CMV-AU) is an important subtype of herpesvirus anterior uveitis, usually unilateral and characterized by recurrent iritis, ocular hypertension, pigmented keratic precipitates, iris atrophy, and corneal endothelial dysfunction. We report a 72-year-old immunocompetent man initially diagnosed with bilateral granulomatous uveitis of unknown origin, who was later confirmed by aqueous humor polymerase chain reaction to have CMV-AU. In retrospect, typical features of CMV-AU were present, but the bilateral involvement and atypical diffuse circumferential peripheral iris atrophy contributed to the delayed diagnosis. Corneal endothelial cell loss and trabecular meshwork depigmentation were also observed, consistent with reported CMV-related findings. The patient was treated with topical ganciclovir prepared from an injectable formulation, together with steroids and anti-glaucoma medications. While trabeculotomy provided some intraocular pressure (IOP) reduction, trabeculectomy proved more effective in achieving long-term IOP stability, consistent with previous reports. This case illustrates that CMV-AU may present bilaterally with atypical features and highlights the importance of early recognition, particularly for ophthalmology residents and general ophthalmologists who are not specialized in uveitis or glaucoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.